<DOC>
	<DOCNO>NCT00477373</DOCNO>
	<brief_summary>To assess efficacy Di-valproate Bipolar I patient suffer manic episode accord DSM IV ( APA 1994 ) 12 week period treatment . To evaluate clinical safety Di-valproate .</brief_summary>
	<brief_title>Gulf Evaluation VAlproate ( Depakine Chrono ) maNia Study</brief_title>
	<detailed_description />
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<criteria>In patient Patients current diagnosis Bipolar I Disorder accord DSM IV ( 296 ) Patients suffer current manic episode mixed episode Patients participate clinical trial within three precede month Patients history valproate intolerance define valproate discontinuation due medically significant adverse effect . Patients CNS neoplasm , demyelinate disease , degenerative neurological disorder , active CNS infection progressive disorder Patients history seizure disorder , cerebral vascular disease , structural brain damage trauma , clinically significant focal neurological abnormality , know EEG frank paroxysmal activity know CT scan brain demonstrating gross structural abnormality Patients uncontrolled gastrointestinal , renal , hepatic , endocrine , cardiovascular , pulmonary , immunological hematological disease Patients acute chronic hepatitis Patients current past pancreatitis Patients recent history ( 3 month less ) substance alcohol dependence accord DSM IV Pregnancy lactation . Women child bear age use reliable contraceptive method Patients require 325 mg aspirin per day Patients medical condition require continuous use medication could interfere evaluation safety efficacy valproate : anticonvulsant anticoagulant therapy , MAO inhibitor , zidovudine Patients receive depot neuroleptic within six week prior baseline Patients receive antidepressant drug within 5 day baseline patient receive fluoxetine within 20 day Patients judge investigator serious risk suicide Patients necessitate Electro Convulsive Therapy The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2008</verification_date>
</DOC>